Moderna Inc (MRNA)
38.26
+1.32
(+3.57%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.05
(-0.13%)
After-Hours: 20:00
Moderna Profit Margin (Quarterly): 0.70% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.70% |
June 30, 2024 | -578.7% |
March 31, 2024 | -703.6% |
December 31, 2023 | 7.71% |
September 30, 2023 | -203.1% |
June 30, 2023 | -436.7% |
March 31, 2023 | 4.30% |
December 31, 2022 | 28.45% |
September 30, 2022 | 32.39% |
June 30, 2022 | 48.12% |
March 31, 2022 | 61.57% |
December 31, 2021 | 70.05% |
September 30, 2021 | 69.02% |
June 30, 2021 | 65.95% |
Date | Value |
---|---|
March 31, 2021 | 70.05% |
December 31, 2020 | -119.2% |
September 30, 2020 | -1.94K% |
June 30, 2020 | -403.4% |
March 31, 2020 | -3.10K% |
December 31, 2019 | -1.17K% |
September 30, 2019 | -923.8% |
June 30, 2019 | -1.35K% |
March 31, 2019 | -939.3% |
December 31, 2018 | -431.0% |
September 30, 2018 | -219.1% |
June 30, 2018 | -350.7% |
March 31, 2018 | -263.6% |
December 31, 2017 | -42.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.10K%
Minimum
Mar 2020
70.05%
Maximum
Dec 2021
-410.0%
Average
2.50%
Median
Profit Margin (Quarterly) Benchmarks
Eli Lilly and Co | 8.48% |
Merck & Co Inc | 18.95% |
Pfizer Inc | 25.22% |
Novavax Inc | -143.5% |
Vertex Pharmaceuticals Inc | 37.71% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -17.44% |
Return on Assets | -12.92% |
Return on Invested Capital | -17.44% |
Gross Profit Margin (Quarterly) | 72.29% |
Operating Margin (Quarterly) | -3.77% |
Return on Net Operating Assets | -45.55% |